Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England

Diabet Med. 2018 Nov;35(11):1617-1618. doi: 10.1111/dme.13766.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administrative Claims, Healthcare / statistics & numerical data
  • Blood Glucose / analysis*
  • Blood Glucose / metabolism
  • Blood Glucose Self-Monitoring / economics
  • Blood Glucose Self-Monitoring / instrumentation
  • Blood Glucose Self-Monitoring / statistics & numerical data
  • Cost-Benefit Analysis
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / economics*
  • Diabetes Mellitus, Type 1 / epidemiology*
  • England / epidemiology
  • Health Services Accessibility / statistics & numerical data*
  • Healthcare Disparities / economics
  • Healthcare Disparities / statistics & numerical data
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / economics
  • Insulin / administration & dosage
  • Insulin / economics
  • Insulin Infusion Systems / economics
  • Insulin Infusion Systems / statistics & numerical data
  • Insurance, Health, Reimbursement / statistics & numerical data*
  • Longitudinal Studies

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin